Form 4 for HRTX HERON THERAPEUTICS, INC. /DE/
Accepted 2021-12-23 00:00:00 ET · period of report 2021-12-21 · accession 0001209191-21-071172 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-23 | 2021-12-22 | HRTX | Christian Waage | Dir | A - Grant | $0.00 | +10.5K | 13.7K | +327% | $0 |
| D | 2021-12-23 | 2021-12-21 | HRTX | Christian Waage | Dir | S - Sale | $9.73 | -300 | 3,200 | -9% | -$2,919 |
| D | 2021-12-23 | 2021-12-22 | HRTX | Christian Waage | Dir | A - Grant | $0.00 | +20.9K | 20.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-22 | A | A | 10,452 | $0.00 | 13,652 | D | — | — | (F3) The shares were granted as restricted stock units which vest in full on December 22, 2022. |
| 2 | Common | Common Stock | 2021-12-21 | S | D | 300 | $9.73 | 3,200 | D | — | — | (F2) The range of sales prices received was $9.625 to $9.945. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-12-22 | A | A | 20,903 | $0.00 | 20,903 | D | $9.81 · — to 2031-12-22 | 20,903 Common Stock | (F4) The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant. |